XOMA Co. (NASDAQ:XOMAO) Short Interest Down 96.0% in November

XOMA Co. (NASDAQ:XOMAOGet Free Report) was the recipient of a large decline in short interest in November. As of November 15th, there was short interest totalling 100 shares, a decline of 96.0% from the October 31st total of 2,500 shares. Based on an average daily volume of 5,200 shares, the short-interest ratio is presently 0.0 days.

XOMA Stock Performance

NASDAQ:XOMAO opened at $25.36 on Friday. The stock’s 50 day moving average price is $25.53 and its 200 day moving average price is $25.33. XOMA has a 52 week low of $22.06 and a 52 week high of $25.87.

About XOMA

(Get Free Report)

XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets.

Read More

Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.